Reviva Pharmaceuticals (RVPH) said late Wednesday it plans a public offering of stock and warrants to purchase shares, with A.G.P./Alliance Global Partners as placement agent.
The late-stage drugmaker said it intends to use the net proceeds to help fund research and development activities.
Shares were down about 39% in after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments